mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
0.063 |
0.3 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.3 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.3 |